EBioMedicine
About EBioMedicine
eBioMedicine covers the spectrum of biomedical research, from preclinical studies with clear human relevance, through to proof-of-concept, first-in-human studies, and early phase clinical trials. We are dedicated to publishing original research that investigates the basic determinants of human health and disease, the discovery and characterization of new therapeutic targets and treatments, and the identification of biomarkers and diagnostic tools which may help researchers and clinicians better understand and monitor disease.
News
10 Jan 2024
Duke-NUS Medical School
Novel findings from a preclinical head-to-head comparison show that administering a COVID-19 vaccine as a nasal spray rather than a subcutaneous injection enhances the body’s long-term immune memory, thereby increasing the vaccine’s overall effectiveness. This research could pave the way for a COVID-19 vaccination strategy that depends on fewer boosters to achieve the same level of protection against SARS-CoV-2 viruses.
03 Sep 2019
Tohoku University
A research collaboration based in Japan has found a new pathological mediator of amyotrophic lateral sclerosis (ALS), which could have further implications for understanding the molecular breakdown that gives rise to the neurodegenerative disease that affects nearly half a million people around the world.